Doubts over Kashmir encounter, 44 at Tablighi event face trial, Russia’s vaccine claim

First, we’re talking with The Indian Express’s Bashaarat Masood in Srinagar about why questions that have been raised about the killing of three militants in Kashmir. Then, we’re talking with The Indian Express’s Sourav Roy Barman about why 44 foreign nationals who were at the controversial Tablighi Jamaat event in New Delhi are choosing to stand trial. (9:09) And finally, we’re looking at Russia’s claim of having developed a COVID-19 vaccine.(20:06)